Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461017 · ClinicalTrials.gov registry record
Endotracheal Tube Audible Leak Test
A clinical trial, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 86
- Enrollment target
NCT02461017: Completed study, sponsored by University of Mississippi Medical Center.
NCT02461017 is a clinical trial that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02461017 has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
The endotracheal tube (ETT) leak test (LT), or audible leak test is a widely performed assessment to verify appropriate tube size in neonates, infants and children. However, many factors are known to influence the audible leak test. Even though the test is widely performed, the accuracy has not been evaluated.
Primary Outcome
Evidence of an audible endotracheal leak and/or direct visualized endotracheal leak using a flexible nasal laryngoscope positioned superior to the laryngeal inlet.
Interventions
- OTHER Assess for Audible Endotracheal Leak
- OTHER Assess for Endotracheal Leak with direct visualization under rigid bronchoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2015-12-07 |
| Est. Completion | 2017-02-21 |
What the finished NCT02461017 record still lists
NCT02461017 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Assess for Audible Endotracheal Leak is the first listed.
NCT02461017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02461017 about?
NCT02461017 is a clinical study titled "Endotracheal Tube Audible Leak Test". The endotracheal tube (ETT) leak test (LT), or audible leak test is a widely performed assessment to verify appropriate tube size in neonates, infants and children. However, many factors are known to influence the audible leak test. Even though the test is widely performed, the accuracy has not been...
What is the current status of trial NCT02461017?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2015-12-07. Estimated completion is 2017-02-21.
What interventions are being tested in trial NCT02461017?
The interventions under investigation include: Assess for Audible Endotracheal Leak (OTHER), Assess for Endotracheal Leak with direct visualization under rigid bronchoscope (OTHER).
Who is sponsoring clinical trial NCT02461017?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI